Petros Pharmaceuticals Inc (PTPI)
0.641
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
0.63
-0.01
(-1.72%)
After-Hours: 20:00
Petros Pharmaceuticals Revenue (Annual): 5.822M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.822M |
| December 31, 2022 | 5.992M |
| December 31, 2021 | 7.811M |
| Date | Value |
|---|---|
| December 31, 2020 | 9.560M |
| December 31, 2019 | 15.58M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.822M
Minimum
2023
15.58M
Maximum
2019
8.952M
Average
7.811M
Median
2021
Revenue (Annual) Benchmarks
| Avalo Therapeutics Inc | 1.924M |
| Imunon Inc | -- |
| iBio Inc | -- |
| Oramed Pharmaceuticals Inc | 1.34M |
| Ocugen Inc | 6.036M |